WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark ADAPT was filed as Word mark on 02/03/2022 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1677688 |
| Countries | 
|
| Base trademark |
No. 90867247,
August 5, 2021
|
| Application date | February 3, 2022 |
| Expiration date | February 3, 2032 |
Trademark owner
11099 North Torrey Pines Road,
Suite 160
US
Suite 160
US
Trademark representatives
425 MARKET STREET
SAN FRANCISCO CA 94105
US
goods and services
05
Pharmaceutical products, preparations, and substances for
the prevention and treatment of cancer, infectious diseases,
allergies, mental illnesses, chemotherapy side effects,
radiation side effects, transplantation side effects, and
viral, metabolic, cardiovascular, vascular, pulmonary,
blood, dermatologic, fibrotic, autoimmune, inflammatory,
neurodegenerative, neuromuscular, dietary deficiency,
hereditary, endocrine, eye, ear, and voice related diseases
and disorders; biological products, preparations, and
substances for the prevention and treatment of cancer,
infectious diseases, allergies, mental illnesses,
chemotherapy side effects, radiation side effects,
transplantation side effects, and viral, metabolic,
cardiovascular, vascular, pulmonary, blood, dermatologic,
fibrotic, autoimmune, inflammatory, neurodegenerative,
neuromuscular, dietary deficiency, hereditary, endocrine,
eye, ear, and voice related diseases and disorders;
immunotherapies for the prevention and treatment of cancer,
infectious diseases, allergies, mental illnesses,
chemotherapy side effects, radiation side effects,
transplantation side effects, and viral, metabolic,
cardiovascular, vascular, pulmonary, blood, dermatologic,
fibrotic, autoimmune, inflammatory, neurodegenerative,
neuromuscular, dietary deficiency, hereditary, endocrine,
eye, ear, and voice related diseases and disorders (term
considered too vague by the International Bureau - Rule 13
(2) (b) of the Regulations); vaccines; biotechnology
platform technology, namely, viral and vaccine vectors for
delivery and insertion of function-altering genetic material
into human and animal patients, plants, and crops, for
visualization of specific cell types, for inducing humoral
and cell-mediated responses, for targeting and killing
cancer cells, for removing pathological functions, for
controlling biological pests, and for boosting crop yields
(term considered too vague by the International Bureau -
Rule 13 (2) (b) of the Regulations)
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| June 16, 2023 | 2023/25 Gaz | EM | Rejection |
| June 1, 2023 | 2023/22 Gaz | JP | Rejection |
| January 4, 2023 | 2023/1 Gaz | GB | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| September 23, 2022 | 2022/42 Gaz | RAW: Limitation | |
| September 12, 2022 | 2022/38 Gaz | EM | Rejection |
| August 26, 2022 | 2022/35 Gaz | GB | Rejection |
| February 3, 2022 | 2022/30 Gaz | US | Registration |
ID: 141677688